Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

The treatment was not recommended due to limited effectiveness and significant side effects.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Tofacitinib is a promising treatment for children with rheumatic diseases.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

Axitinib treatment turned a man's grey hair back to black.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Nostoc verrucosum extracts may help reduce melanin production and have antioxidant properties.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Oral minoxidil may effectively treat hair loss from chemotherapy.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Methotrexate is generally safe and often effective for treating hair loss in children.

Bortezomib chemotherapy can cause temporary skin rashes.

Topical minoxidil showed promise for early male pattern baldness.

Compound 1 showed promising anticancer activity.

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Clofazimine may be effective for treating ashy dermatosis.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.